메뉴 건너뛰기




Volumn 44, Issue 5, 2014, Pages 919-926

Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer

Author keywords

Cisplatin; Hyaluronic acid; Hydrogel; Intraperitoneal chemotherapy; Peritoneal dissemination

Indexed keywords

BIOMATERIAL; CISPLATIN; HYALURONIC ACID; POLYMER;

EID: 84899929502     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-013-0674-6     Document Type: Article
Times cited : (55)

References (49)
  • 4
    • 21844443897 scopus 로고    scopus 로고
    • Treatment of peritoneal carcinomatosis in gastric cancers
    • DOI 10.1159/000083600
    • Brigand C, Arvieux C, Gilly FN, Glehen O. Treatment of peritoneal carcinomatosis in gastric cancers. Dig Dis. 2004;22(4):366-73. (Pubitemid 41201477)
    • (2004) Digestive Diseases , vol.22 , Issue.4 , pp. 366-373
    • Brigand, C.1    Arvieux, C.2    Gilly, F.N.3    Glehen, O.4
  • 5
    • 34250171686 scopus 로고    scopus 로고
    • Intraperitoneal paclitaxel: A possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma
    • Kodera Y, Ito Y, Ito S, Ohashi N, Mochizuki Y, Yamamura Y, Koike M, Fujiwara M, Nakanishi H, Nakao A. Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma. Hepatogastroenterology. 2007;54(75):960-3. (Pubitemid 46903764)
    • (2007) Hepato-Gastroenterology , vol.54 , Issue.75 , pp. 960-963
    • Kodera, Y.1    Ito, Y.2    Ito, S.3    Ohashi, N.4    Mochizuki, Y.5    Yamamura, Y.6    Koike, M.7    Fujiwara, M.8    Nakanishi, H.9    Nakao, A.10
  • 8
    • 0028862180 scopus 로고
    • Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: A Gynecologic Oncology Group pilot Study
    • Francis P, Rowinsky E, Schneider J, Hakes T, Hoskins W, Markman M. Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot Study. J Clin Oncol. 1995;13(12):2961-7.
    • (1995) J Clin Oncol , vol.13 , Issue.12 , pp. 2961-2967
    • Francis, P.1    Rowinsky, E.2    Schneider, J.3    Hakes, T.4    Hoskins, W.5    Markman, M.6
  • 11
    • 13844311027 scopus 로고    scopus 로고
    • Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy
    • DOI 10.1634/theoncologist.10-2-112
    • Sugarbaker PH, Mora JT, Carmignani P, Stuart OA, Yoo D. Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. Oncologist. 2005;10(2):112-22. (Pubitemid 40261950)
    • (2005) Oncologist , vol.10 , Issue.2 , pp. 112-122
    • Sugarbaker, P.H.1    Mora, J.T.2    Carmignani, P.3    Stuart, O.A.4    Yoo, D.5
  • 12
    • 0030909491 scopus 로고    scopus 로고
    • Pharmacokinetic problems in peritoneal drug administration: Tissue penetration and surface exposure
    • Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst. 1997;89(7):480-7. (Pubitemid 27147264)
    • (1997) Journal of the National Cancer Institute , vol.89 , Issue.7 , pp. 480-487
    • Dedrick, R.L.1    Flessner, M.F.2
  • 13
    • 79952570779 scopus 로고    scopus 로고
    • Intraperitoneal drug delivery for ovarian cancer: Why, how, who, what, and when?
    • (Williston Park)
    • Echarri Gonzalez MJ, Green R, Muggia FM. Intraperitoneal drug delivery for ovarian cancer: why, how, who, what, and when? Oncology (Williston Park). 2011;25(2):156-165, 170.
    • (2011) Oncology , vol.25 , Issue.2
    • Echarri Gonzalez, M.J.1    Green, R.2    Muggia, F.M.3
  • 14
    • 33644908789 scopus 로고    scopus 로고
    • Intraperitoneal chemotherapy of ovarian cancer: A review, with a focus on practical aspects of treatment
    • DOI 10.1200/JCO.2005.05.2456
    • Markman M, Walker JL. Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment. J Clin Oncol. 2006;24(6):988-94. (Pubitemid 46638854)
    • (2006) Journal of Clinical Oncology , vol.24 , Issue.6 , pp. 988-994
    • Markman, M.1    Walker, J.L.2
  • 15
    • 77953289893 scopus 로고    scopus 로고
    • Drug delivery systems for intraperitoneal therapy
    • Bajaj G, Yeo Y. Drug delivery systems for intraperitoneal therapy. Pharm Res. 2010;27(5):735-8.
    • (2010) Pharm Res , vol.27 , Issue.5 , pp. 735-738
    • Bajaj, G.1    Yeo, Y.2
  • 16
    • 0029999741 scopus 로고    scopus 로고
    • Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice
    • Kondo A, Maeta M, Oka A, Tsujitani S, Ikeguchi M, Kaibara N. Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice. Br J Cancer. 1996;73(10):1166-70. (Pubitemid 26162328)
    • (1996) British Journal of Cancer , vol.73 , Issue.10 , pp. 1166-1170
    • Kondo, A.1    Maeta, M.2    Oka, A.3    Tsujitani, S.4    Ikeguchi, M.5    Kaibara, N.6
  • 17
    • 0032988729 scopus 로고    scopus 로고
    • Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats
    • DOI 10.1159/000012004
    • Tsujitani S, Oka A, Kondo A, Katano K, Oka S, Saito H, Ikeguchi M, Maeta M, Kaibara N. Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats. Oncology. 1999;57(1):77-82. (Pubitemid 29308675)
    • (1999) Oncology , vol.57 , Issue.1 , pp. 77-82
    • Tsujitani, S.1    Oka, A.2    Kondo, A.3    Katano, K.4    Oka, S.5    Saito, H.6    Ikeguchi, M.7    Maeta, M.8    Kaibara, N.9
  • 18
    • 0038632303 scopus 로고    scopus 로고
    • Intraperitoneal antineoplastic drug delivery: Rationale and results
    • DOI 10.1016/S1470-2045(03)01074-X
    • Markman M. Intraperitoneal antineoplastic drug delivery: rationale and results. Lancet Oncol. 2003;4(5):277-83. (Pubitemid 36603295)
    • (2003) Lancet Oncology , vol.4 , Issue.5 , pp. 277-283
    • Markman, M.1
  • 19
    • 40749086094 scopus 로고    scopus 로고
    • Pharmacologic principles of intraperitoneal chemotherapy for the treatment of ovarian cancer
    • DOI 10.1111/j.1525-1438.2007.01099.x
    • Howell SB. Pharmacologic principles of intraperitoneal chemotherapy for the treatment of ovarian cancer. Int J Gynecol Cancer. 2008;18(Suppl 1):20-5. (Pubitemid 351389048)
    • (2008) International Journal of Gynecological Cancer , vol.18 , Issue.SUPPL. 1 , pp. 20-25
    • Howell, S.B.1
  • 20
    • 0034601831 scopus 로고    scopus 로고
    • Cross-linked hyaluronic acid hydrogel films: New biomaterials for drug delivery
    • Luo Y, Kirker KR, Prestwich GD. Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J Control Release. 2000;69(1):169-84.
    • (2000) J Control Release , vol.69 , Issue.1 , pp. 169-184
    • Luo, Y.1    Kirker, K.R.2    Prestwich, G.D.3
  • 21
    • 77955072472 scopus 로고    scopus 로고
    • 5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice
    • Wang Y, Gong C, Yang L, Wu Q, Shi S, Shi H, Qian Z, Wei Y. 5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice. BMC Cancer. 2010;10:402.
    • (2010) BMC Cancer , vol.10 , pp. 402
    • Wang, Y.1    Gong, C.2    Yang, L.3    Wu, Q.4    Shi, S.5    Shi, H.6    Qian, Z.7    Wei, Y.8
  • 22
    • 84856513525 scopus 로고    scopus 로고
    • The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model
    • Yu J, Lee HJ, Hur K, Kwak MK, Han TS, Kim WH, Song SC, Yanagihara K, Yang HK. The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model. Invest New Drugs. 2012;30(1):1-7.
    • (2012) Invest New Drugs , vol.30 , Issue.1 , pp. 1-7
    • Yu, J.1    Lee, H.J.2    Hur, K.3    Kwak, M.K.4    Han, T.S.5    Kim, W.H.6    Song, S.C.7    Yanagihara, K.8    Yang, H.K.9
  • 23
    • 0035981078 scopus 로고    scopus 로고
    • Environment-sensitive hydrogels for drug delivery
    • DOI 10.1016/S0169-409X(01)00203-4, PII S0169409X01002034
    • Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev. 2001;53(3):321-39. (Pubitemid 34024913)
    • (2001) Advanced Drug Delivery Reviews , vol.53 , Issue.3 , pp. 321-339
    • Qiu, Y.1    Park, K.2
  • 24
    • 77952238688 scopus 로고    scopus 로고
    • Suppression of in vivo tumor growth by using a biodegradable thermosensitive hydrogel polymer containing chemotherapeutic agent
    • Kwak MK, Hur K, Yu JE, Han TS, Yanagihara K, Kim WH, Lee SM, Song SC, Yang HK. Suppression of in vivo tumor growth by using a biodegradable thermosensitive hydrogel polymer containing chemotherapeutic agent. Invest New Drugs. 2010;28(3):284-90.
    • (2010) Invest New Drugs , vol.28 , Issue.3 , pp. 284-290
    • Kwak, M.K.1    Hur, K.2    Yu, J.E.3    Han, T.S.4    Yanagihara, K.5    Kim, W.H.6    Lee, S.M.7    Song, S.C.8    Yang, H.K.9
  • 25
    • 80051786334 scopus 로고    scopus 로고
    • Drug release behaviors of a pH sensitive semi-interpenetrating polymer network hydrogel composed of poly(vinyl alcohol) and star poly[2-(dimethylamino) ethyl methacrylate]
    • Wu W, Liu J, Cao S, Tan H, Li J, Xu F, Zhang X. Drug release behaviors of a pH sensitive semi-interpenetrating polymer network hydrogel composed of poly(vinyl alcohol) and star poly[2-(dimethylamino) ethyl methacrylate]. Int J Pharm. 2011;416(1):104-9.
    • (2011) Int J Pharm , vol.416 , Issue.1 , pp. 104-109
    • Wu, W.1    Liu, J.2    Cao, S.3    Tan, H.4    Li, J.5    Xu, F.6    Zhang, X.7
  • 26
    • 42049097246 scopus 로고    scopus 로고
    • In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery
    • He C, Kim SW, Lee DS. In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J Control Release. 2008;127(3):189-207.
    • (2008) J Control Release , vol.127 , Issue.3 , pp. 189-207
    • He, C.1    Kim, S.W.2    Lee, D.S.3
  • 29
    • 0033200301 scopus 로고    scopus 로고
    • Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate
    • DOI 10.1021/bc9900338
    • Luo Y, Prestwich GD. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjug Chem. 1999;10(5):755-63. (Pubitemid 29456361)
    • (1999) Bioconjugate Chemistry , vol.10 , Issue.5 , pp. 755-763
    • Luo, Y.1    Prestwich, G.D.2
  • 30
    • 33847224482 scopus 로고    scopus 로고
    • Injectable hyaluronic acid microhydrogels for controlled release formulation of erythropoietin
    • Hahn SK, Kim JS, Shimobouji T. Injectable hyaluronic acid microhydrogels for controlled release formulation of erythropoietin. J Biomed Mater Res A. 2007;80(4):916-24.
    • (2007) J Biomed Mater Res A , vol.80 , Issue.4 , pp. 916-924
    • Hahn, S.K.1    Kim, J.S.2    Shimobouji, T.3
  • 32
    • 33745031294 scopus 로고    scopus 로고
    • In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit model
    • DOI 10.1016/j.biomaterials.2006.04.043, PII S0142961206004376
    • Yeo Y, Highley CB, Bellas E, Ito T, Marini R, Langer R, Kohane DS. In situ cross-linkable hyaluronic acid hydrogels prevent postoperative abdominal adhesions in a rabbit model. Biomaterials. 2006;27(27):4698-705. (Pubitemid 43870121)
    • (2006) Biomaterials , vol.27 , Issue.27 , pp. 4698-4705
    • Yeo, Y.1    Highley, C.B.2    Bellas, E.3    Ito, T.4    Marini, R.5    Langer, R.6    Kohane, D.S.7
  • 33
    • 33751398917 scopus 로고    scopus 로고
    • The prevention of peritoneal adhesions by in situ cross-linking hydrogels of hyaluronic acid and cellulose derivatives
    • DOI 10.1016/j.biomaterials.2006.10.021, PII S0142961206009239
    • Ito T, Yeo Y, Highley CB, Bellas E, Benitez CA, Kohane DS. The prevention of peritoneal adhesions by in situ cross-linking hydrogels of hyaluronic acid and cellulose derivatives. Biomaterials. 2007;28(6):975-83. (Pubitemid 44816378)
    • (2007) Biomaterials , vol.28 , Issue.6 , pp. 975-983
    • Ito, T.1    Yeo, Y.2    Highley, C.B.3    Bellas, E.4    Benitez, C.A.5    Kohane, D.S.6
  • 34
    • 2442640516 scopus 로고    scopus 로고
    • Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer
    • DOI 10.1158/0008-5472.CAN-04-0304
    • Sako A, Kitayama J, Koyama H, Ueno H, Uchida H, Hamada H, Nagawa H. Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer. Cancer Res. 2004;64(10):3624-8. (Pubitemid 38657941)
    • (2004) Cancer Research , vol.64 , Issue.10 , pp. 3624-3628
    • Sako, A.1    Kitayama, J.2    Koyama, H.3    Ueno, H.4    Uchida, H.5    Hamada, H.6    Nagawa, H.7
  • 35
    • 0032819928 scopus 로고    scopus 로고
    • New strategy for chemical modification of hyaluronic acid: Preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels
    • DOI 10.1002/(SICI)1097-4636(199911)47:2<152::AID-J
    • Bulpitt P, Aeschlimann D. New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J Biomed Mater Res. 1999;47(2):152-69. (Pubitemid 29409734)
    • (1999) Journal of Biomedical Materials Research , vol.47 , Issue.2 , pp. 152-169
    • Bulpitt, P.1    Aeschlimann, D.2
  • 36
    • 2342444880 scopus 로고    scopus 로고
    • Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid
    • DOI 10.1016/j.biomaterials.2003.12.012, PII S0142961203011591
    • Jia X, Colombo G, Padera R, Langer R, Kohane DS. Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid. Biomaterials. 2004;25(19):4797-804. (Pubitemid 38561167)
    • (2004) Biomaterials , vol.25 , Issue.19 , pp. 4797-4804
    • Jia, X.1    Colombo, G.2    Padera, R.3    Langer, R.4    Kohane, D.S.5
  • 37
    • 77951551833 scopus 로고    scopus 로고
    • Pharmacokinetics and disposition of a localized lymphatic polymeric hyaluronan conjugate of cisplatin in rodents
    • Cai S, Xie Y, Davies NM, Cohen MS, Forrest ML. Pharmacokinetics and disposition of a localized lymphatic polymeric hyaluronan conjugate of cisplatin in rodents. J Pharm Sci. 2010;99(6):2664-71.
    • (2010) J Pharm Sci , vol.99 , Issue.6 , pp. 2664-2671
    • Cai, S.1    Xie, Y.2    Davies, N.M.3    Cohen, M.S.4    Forrest, M.L.5
  • 38
    • 84862777576 scopus 로고    scopus 로고
    • Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors
    • Bajaj G, Kim MR, Mohammed SI, Yeo Y. Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors. J Control Release. 2012;158(3):386-92.
    • (2012) J Control Release , vol.158 , Issue.3 , pp. 386-392
    • Bajaj, G.1    Kim, M.R.2    Mohammed, S.I.3    Yeo, Y.4
  • 39
    • 0032588952 scopus 로고    scopus 로고
    • CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells
    • Lessan K, Aguiar DJ, Oegema T, Siebenson L, Skubitz AP. CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am J Pathol. 1999;154(5):1525-37. (Pubitemid 29226447)
    • (1999) American Journal of Pathology , vol.154 , Issue.5 , pp. 1525-1537
    • Lessan, K.1    Aguiar, D.J.2    Oegema, T.3    Siebenson, L.4    Skubitz, A.P.N.5
  • 40
    • 29544431803 scopus 로고    scopus 로고
    • Endothelial adhesion of synchronized gastric tumor cells changes during cell cycle transit and correlates with the expression level of CD44 splice variants
    • Oertl A, Castein J, Engl T, Beecken WD, Jonas D, Melamed R, Blaheta RA. Endothelial adhesion of synchronized gastric tumor cells changes during cell cycle transit and correlates with the expression level of CD44 splice variants. World J Gastroenterol. 2005;11(40):6243-8. (Pubitemid 43013988)
    • (2005) World Journal of Gastroenterology , vol.11 , Issue.40 , pp. 6243-6248
    • Oertl, A.1    Castein, J.2    Engl, T.3    Beecken, W.-D.4    Jonas, D.5    Melamed, R.6    Blaheta, R.A.7
  • 42
    • 79953042645 scopus 로고    scopus 로고
    • CD44: Can a cancer-initiating cell profit from an abundantly expressed molecule?
    • Zoller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer. 2011;11(4):254-67.
    • (2011) Nat Rev Cancer , vol.11 , Issue.4 , pp. 254-267
    • Zoller, M.1
  • 44
    • 0021843888 scopus 로고
    • Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatin
    • Takahashi K, Seki T, Nishikawa K, Minamide S, Iwabuchi M, Ono M, Nagamine S, Horinishi H. Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatin. Jpn J Cancer Res. 1985;76(1):68-74. (Pubitemid 15050358)
    • (1985) Japanese Journal of Cancer Research , vol.76 , Issue.1 , pp. 68-74
    • Takahashi, K.1    Seki, T.2    Nishikawa, K.3
  • 45
    • 34249901034 scopus 로고    scopus 로고
    • Peritoneal adhesion prevention with an in situ cross-linkable hyaluronan gel containing tissue-type plasminogen activator in a rabbit repeated-injury model
    • DOI 10.1016/j.biomaterials.2007.04.033, PII S0142961207003547
    • Yeo Y, Bellas E, Highley CB, Langer R, Kohane DS. Peritoneal adhesion prevention with an in situ cross-linkable hyaluronan gel containing tissue-type plasminogen activator in a rabbit repeated-injury model. Biomaterials. 2007;28(25):3704-13. (Pubitemid 46863374)
    • (2007) Biomaterials , vol.28 , Issue.25 , pp. 3704-3713
    • Yeo, Y.1    Bellas, E.2    Highley, C.B.3    Langer, R.4    Kohane, D.S.5
  • 47
    • 78650226437 scopus 로고    scopus 로고
    • Spatial distribution of intraperitoneally administrated paclitaxel nanoparticles solubilized with poly (2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) in peritoneal metastatic nodules
    • Kamei T, Kitayama J, Yamaguchi H, Soma D, Emoto S, Konno T, Ishihara K, Ishigami H, Kaisaki S, Nagawa H. Spatial distribution of intraperitoneally administrated paclitaxel nanoparticles solubilized with poly (2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) in peritoneal metastatic nodules. Cancer Sci. 2010;102(1):200-5.
    • (2010) Cancer Sci , vol.102 , Issue.1 , pp. 200-205
    • Kamei, T.1    Kitayama, J.2    Yamaguchi, H.3    Soma, D.4    Emoto, S.5    Konno, T.6    Ishihara, K.7    Ishigami, H.8    Kaisaki, S.9    Nagawa, H.10
  • 48
    • 0034208501 scopus 로고    scopus 로고
    • A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells
    • Luo Y, Ziebell MR, Prestwich GD. A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules. 2000;1(2):208-18.
    • (2000) Biomacromolecules , vol.1 , Issue.2 , pp. 208-218
    • Luo, Y.1    Ziebell, M.R.2    Prestwich, G.D.3
  • 49
    • 43549084331 scopus 로고    scopus 로고
    • Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate
    • Cai S, Xie Y, Bagby TR, Cohen MS, Forrest ML. Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate. J Surg Res. 2008;147(2):247-52.
    • (2008) J Surg Res , vol.147 , Issue.2 , pp. 247-252
    • Cai, S.1    Xie, Y.2    Bagby, T.R.3    Cohen, M.S.4    Forrest, M.L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.